|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 42.9 TWD | -0.23% |
|
+1.54% | -11.36% |
Maxigen Biotech Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 604.43 million compared to TWD 511.98 million a year ago. Net income was TWD 139.4 million compared to TWD 87.67 million a year ago.
Basic earnings per share from continuing operations was TWD 1.5714 compared to TWD 1.0381 a year ago. Diluted earnings per share from continuing operations was TWD 1.5619 compared to TWD 1.0381 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.36% | 118M | |
| -2.16% | 254B | |
| +12.81% | 19.89B | |
| 0.00% | 18.26B | |
| +0.38% | 11.16B | |
| +16.34% | 7.63B | |
| +10.15% | 5.97B | |
| +1.12% | 4.65B | |
| -17.29% | 3.81B | |
| -5.56% | 3.54B |
MAXIGEN BIOTECH INC. 
